Totally agree that if its FIfe again on the second

Totally agree that if its FIfe again on the second $25 million it does show very high confidence by that investor.

If for production, he's stockpiling more leronlimab because he thinks some incremental leronlimab supply will spike the share price even higher when the existing inventory sells out.

Doesn't seem like what "the smartest minds on wall street", as Pourhassan described in the proactive vide, would do. But as I said I know with 100% certainty that the situation is confusing to me

I don't think Fife would put more money in to expand inventory.

So I guess 1) its either a new investor who just wants in and doesn't care what its spent on, or 2) more money for more trials.

Either situation, a new investor wanting in or Fife spending for more money on more trials is very, very bullish.

That is why Cytodyn is so confounding to me. Investors are just pouring the cash in nonstop while the management team is either ignorant or dishonest on program progress. I just don't get it.